Accessibility Menu
 
Biotech Growth Trust Plc logo

Biotech Growth Trust Plc

(LSE) BIOG

Current Price$1318.77
Market Cap$26.39B
Since IPO (1997)+1,140%
5 Year-6%
1 Year+93%
1 Month+9%

Biotech Growth Trust Plc Financials at a Glance

Market Cap

$26.39B

Revenue (TTM)

$86.00M

Net Income (TTM)

$75.10M

EPS (TTM)

$-14.30

P/E Ratio

-93.29

Dividend

$0.00

Beta (Volatility)

0.01 (Low)

Price

$1318.77

Volume

3,279

Open

$1310.66

Previous Close

$1334.00

Daily Range

$1310.66 - $1318.78

52-Week Range

$674.00 - $1336.00

BIOG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biotech Growth Trust Plc

Industry

Capital Markets

Employees

0

Headquarters

New York City, NY 10022, US

BIOG Financials

Key Financial Metrics (TTM)

Gross Margin

-5%

Operating Margin

1%

Net Income Margin

1%

Return on Equity

-7%

Return on Capital

-6%

Return on Assets

-7%

Earnings Yield

-1.07%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$26.39B

Shares Outstanding

19.78M

Volume

3.28K

Short Interest

0.00%

Avg. Volume

69.40K

Financials (TTM)

Gross Profit

$78.81M

Operating Income

$82.52M

EBITDA

$82.52M

Operating Cash Flow

$5.09M

Capital Expenditure

$0.00

Free Cash Flow

$5.09M

Cash & ST Invst.

$8.45M

Total Debt

$0.00

Biotech Growth Trust Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$71.20M

+782.5%

Gross Profit

$70.11M

+689.7%

Gross Margin

98.47%

N/A

Market Cap

$26.39B

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

$69.42M

+85.6%

EBITDA

$69.69M

+669.0%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$27.71M

-233.7%

Accounts Receivable

$8.21M

+543.1%

Inventory

$0.00

+100.0%

Long Term Debt

$27.71M

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-7.36%

N/A

Return on Invested Capital

-6.31%

N/A

Free Cash Flow

$2.52M

-5.1%

Operating Cash Flow

$2.52M

-5.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IBT.LInternational Biotechnology Trust plc
$984.87+0.09%
CMPG.LCT Global Managed Portfolio Growth Ord
$303.00+0.66%
DIVI.LThe Diverse Income Trust plc
$116.75-1.06%
PEMB.LPembroke VCT plc
$92.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
EFOIEnergy Focus
$6.49+2.11%
NVDANvidia
$201.68+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.90+0.06%
TQQQProShares Trust - ProShares UltraPro Qqq
$58.59+0.04%

Questions About BIOG

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.